Compounds > topotecan
Page last updated: 2024-08-24

topotecan and beta-escin

topotecan has been researched along with beta-escin in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Du, HZ; Feng, SY; Li, RM; Lin, S; Luo, XJ; Qian, CM; Sun, L; Yu, BY; Yu, XW; Yuan, ST; Zhang, LY; Zhao, RP1
Chen, X; Du, H; Hou, X; Li, H; Lin, S; Liu, Y; Lu, L; Sun, L; Yu, X; Yuan, S; Zhan, M1
Du, HZ; Gao, YS; Li, RM; Luo, XJ; Qian, CM; Sun, L; Wang, JS; Wei, D; Yu, BY; Yu, XW; Yuan, ST1

Other Studies

3 other study(ies) available for topotecan and beta-escin

ArticleYear
Synergistic combination of DT-13 and topotecan inhibits human gastric cancer via myosin IIA-induced endocytosis of EGF receptor in vitro and in vivo.
    Oncotarget, 2016, May-31, Volume: 7, Issue:22

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Drug Synergism; Endocytosis; ErbB Receptors; Female; HEK293 Cells; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Nonmuscle Myosin Type IIA; Saponins; Signal Transduction; Stomach Neoplasms; Topotecan; Xenograft Model Antitumor Assays

2016
DT-13 synergistically potentiates the sensitivity of gastric cancer cells to topotecan via cell cycle arrest in vitro and in vivo.
    European journal of pharmacology, 2018, Jan-05, Volume: 818

    Topics: Antineoplastic Agents; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Humans; Saponins; Stomach Neoplasms; Topotecan

2018
Synergistic combination of DT-13 and Topotecan inhibits aerobic glycolysis in human gastric carcinoma BGC-823 cells via NM IIA/EGFR/HK II axis.
    Journal of cellular and molecular medicine, 2019, Volume: 23, Issue:10

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cell Line, Tumor; Cyclic AMP Response Element-Binding Protein; Drug Synergism; Endocytosis; ErbB Receptors; Female; Glycolysis; Hexokinase; Humans; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred BALB C; Mice, Nude; Mitochondria; Nonmuscle Myosin Type IIA; RNA, Small Interfering; Saponins; Stomach Neoplasms; Topotecan; Xenograft Model Antitumor Assays

2019